Castor News | Sep 19, 2024
Castor has increased the number of courses for EDC CDMS to 17 and Certification to 12, and added a new category called 'role' with 4 courses...
Brought to you by RivalSense - an AI tool for monitoring any company.
RivalSense tracks the most important product launches, fundraising news, partnerships, hiring activities, pricing changes, tech news, vendors, corporate filings, media mentions, and other developments of companies you're following 💡
Castor
🌎 castoredc.comCastor is a health-tech company based in New York, NY, specializing in providing a comprehensive eClinical data management platform for clinical trials. They focus on making patient-centered clinical trials accessible worldwide by leveraging technology to optimize every aspect of the trial process.
Updates as of Sep 19, 2024
- Castor has increased the number of courses for EDC CDMS to 17 and Certification to 12, and added a new category called 'role' with 4 courses.
- Derk Arts, CEO of Castor, will discuss PRO data capture with Ari Gnanasakthy and Willie Muehlhausen in a webinar on September 18.
- Castor Electronic Data Capture was used for randomization in a study evaluating the effectiveness of the SNapp intervention to increase daily steps.
- CastorEDC is being used for data management and randomization in a study on the effects of a soft exosuit on gait performance in people with incomplete spinal cord injury.
- Derk Arts, MD PhD, will discuss FDA's comments on studies with PROs on September 18.
- Castor's Founder & CEO Derk Arts MD PhD will discuss technology considerations for RWE studies on September 11, 2024.
Did you find it useful?
If you liked this report, consider following your own companies of interest. Receive weekly insights directly to your inbox using RivalSense.